Practice Expertise
Areas of Practice
- Corporate / M&A
- Healthcare & Life Sciences
- Start-ups & Venture Capital
Profile
Oerjan Wickart works as an Attorney at Law at Walder Wyss. He advises clients in the fields of commercial and corporate law, mergers & acquisitions, private equity, venture capital and financings.
Oerjan Wickart studied law at the University of Basel (BLaw 2020, MLaw 2022) and passed the bar exam in the Canton of Basel-Stadt in 2024. Prior to joining Walder Wyss, he gained professional experience at the Criminal Court of Basel-Stadt and at business law firms in Basel and Zurich.
Oerjan Wickart practices in German and English. He is registered with the Bar Register of the Canton of Basel-Stadt and is admitted to practice throughout Switzerland.
Oerjan Wickart studied law at the University of Basel (BLaw 2020, MLaw 2022) and passed the bar exam in the Canton of Basel-Stadt in 2024. Prior to joining Walder Wyss, he gained professional experience at the Criminal Court of Basel-Stadt and at business law firms in Basel and Zurich.
Oerjan Wickart practices in German and English. He is registered with the Bar Register of the Canton of Basel-Stadt and is admitted to practice throughout Switzerland.
Areas of Practice
- Corporate / M&A
- Healthcare & Life Sciences
- Start-ups & Venture Capital
Professional Career
Significant Accomplishments
Blockstrom wird Teil der Ista-Gruppe
Walder Wyss advises UVC Partners as lead investor in USD 24 million financing round of Metafuels AG
CHF 10 Mio. Seed Finanzierungsrunde von TECregen
Allegria Therapeutics Raises USD 5.1M in Seed Extension Funding
AstraZeneca exercises option to buy SixPeaks Bio
ZEISS Vision Care invests in Ocumeda and plans to scale the leading teleophthalmology platform with Fielmann Group
Dec Group and capiton welcome ICG as financial partner to accelerate growth and expand market leadership
NUCLIDIUM Closes CHF 79 Million (EUR 84 Million) Series B Financing to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
EQT Life Sciences Leads USD 80 Million Series A Funding Round in Mosanna Therapeutics
Baculus Holding AG übernimmt Twing Group AG
DA Pet Supplies AG übernimmt das Delphin-Amazonia Geschäft im Rahmen eines Asset Deals
KARL STORZ acquires Anklin
Blockstrom wird Teil der Ista-Gruppe
Walder Wyss advises UVC Partners as lead investor in USD 24 million financing round of Metafuels AG
CHF 10 Mio. Seed Finanzierungsrunde von TECregen
Allegria Therapeutics Raises USD 5.1M in Seed Extension Funding
AstraZeneca exercises option to buy SixPeaks Bio
ZEISS Vision Care invests in Ocumeda and plans to scale the leading teleophthalmology platform with Fielmann Group
Dec Group and capiton welcome ICG as financial partner to accelerate growth and expand market leadership
NUCLIDIUM Closes CHF 79 Million (EUR 84 Million) Series B Financing to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
EQT Life Sciences Leads USD 80 Million Series A Funding Round in Mosanna Therapeutics
Baculus Holding AG übernimmt Twing Group AG
DA Pet Supplies AG übernimmt das Delphin-Amazonia Geschäft im Rahmen eines Asset Deals
KARL STORZ acquires Anklin
Meet our Firms and Professionals
WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.